Milford, Massachusetts, United States
Dynamic senior account manager with an outstanding record of quantifiable achievements in outside sales, business development, customer retention and organizational leadership. Direct the sales and account management of healthcare accounts in the New England area. Expand existing relationships inclusive of large medical institutons, private practices and community health centers. Daily interations with C-level medical directors, forging relationships to successfully partner with facilities to gain formulary approval for various products.
- Selling a prophylactic Biologic (Human Plasma) medication to Allergist,Immunologist and ER - Managing Hospitals in MA,RI,NH,ME & VT - Orphan Medication administered by Infusion
Finished 1st Quarter 114.67% of Goal Promoting Seroquel XR Finished 2nd Quarter 100.74% of Goal Promoting Seroquel XR Finished 3rd Quarter 93.66% of Goal Promoting Seroquel XR Was awarded with 2011 Cornerstone Award for CNS Division
• Promoted in 2010 to Hospital Specialty Account Manager for the Launch of a new Psychiatry Medication. • Successfully partnered with St. Elizabeth and Mclean Hospital to gain formulary approval for Fanapt. • Leads the entire district in prescription volume and volume change. • Exceeded 100% of goal for product portfolio in 2009: Diovan 100.98%, Tekturna 104.28% and Exforge 112.50%. • Finished 2008 ranked 4th out of 26 representative; receiving a retention bonus for finishing in top 5% for 2008 along with stock options. • Received the 2008 MVP award for Massachusettes in conjunction with receiving the top growth team nationally. • Played integral part in solidifying approval for Exforge on Medventive Formulary in 2008. • Exceeded 100% of goal for hypertensive product portfolio in 2008: Diovan, Exforge & Tekturna. • Finished 2008 with highest marketshare for Diovan in Massachusetts with 56.44%. • Finished 2008 with highest ACB share for Exforge in Massachusetts with 63.36%. • Elected member of the Massachusetts CDM Committee.